Comments

Phathom Pharmaceuticals Calificaciones de analistas

PHATNASDAQ

Logotipo presentado por Benzinga Data

Comercio con el público

$14.41

-0.15-1.03%

al cierre: Nov 17, 4:00 PM EST

$14.41

N/A

After hour: 4:00 PM EST

Panorámica general Noticias Beneficios Opciones Pronóstico

Calificaciones de analistas

Operaciones de insiders Interés en corto Informe de acciones

Calificación de consenso¹

Buy

Precio objetivo más alto¹

$30.00

Precio objetivo más bajo¹

$5.00

Precio objetivo consensuado¹

$20.29

Calificaciones de analistas, precios objetivo, pronóstico

Phathom Pharmaceuticals Inc tiene un precio objetivo de consenso de $20.29 basado en las calificaciones de 8 analistas. El máximo es $30, emitido por BMO Capital el marzo 1, 2023. El mínimo es $5, emitido por Goldman Sachs el mayo 2, 2025. Las 3 calificaciones de analistas más recientes fueron publicadas por HC Wainwright & Co., Craig-Hallum y HC Wainwright & Co. el octubre 31, 2025, junio 9, 2025 y junio 9, 2025, respectivamente. Con un precio objetivo promedio de $21 entre HC Wainwright & Co., Craig-Hallum y HC Wainwright & Co., hay una 45.73% upside implícita para Phathom Pharmaceuticals Inc según estas calificaciones más recientes de analistas.

Tendencia de los analistas

jun

oct

Compra

Mantener

Venta

Venta fuerte

Calificación de analistas

4.0

Compra

Compra fuerte

Compra

Mantener

Venta

Venta fuerte

Firmas de analistas que realizan recomendaciones¹

HC Wainwright & Co.

Craig-Hallum

Needham

Goldman Sachs

Guggenheim

¹calculado a partir de las calificaciones de los analistas

Calificaciones de analistas para Phathom Pharmaceuticals

	Buy Now							Get Alert
10/31/2025	Buy Now	80.43%	HC Wainwright & Co.	Matthew Caufield75%	$20 → $26	Maintains	Buy	Get Alert
06/09/2025	Buy Now	17.97%	Craig-Hallum	Chase Knickerbocker74%	$12 → $17	Maintains	Buy	Get Alert
06/09/2025	Buy Now	38.79%	HC Wainwright & Co.	Matthew Caufield75%	$20 → $20	Reiterates	Buy → Buy	Get Alert
06/06/2025	Buy Now	94.31%	Needham	Joseph Stringer75%	$28 → $28	Maintains	Buy	Get Alert
05/02/2025	Buy Now	-16.72%	Craig-Hallum	Chase Knickerbocker74%	$19 → $12	Maintains	Buy	Get Alert
05/02/2025	Buy Now	-65.3%	Goldman Sachs	Paul Choi61%	$10 → $5	Maintains	Neutral	Get Alert
05/02/2025	Buy Now	-16.72%	Guggenheim	Yatin Suneja72%	$18 → $12	Maintains	Buy	Get Alert
05/02/2025	Buy Now	38.79%	HC Wainwright & Co.	Matthew Caufield75%	$28 → $20	Maintains	Buy	Get Alert
04/21/2025	Buy Now	94.31%	Needham	Joseph Stringer75%	$28 → $28	Reiterates	Buy → Buy	Get Alert
04/17/2025	Buy Now	-30.6%	Goldman Sachs	Paul Choi61%	$12 → $10	Maintains	Neutral	Get Alert
04/09/2025	Buy Now	94.31%	Needham	Joseph Stringer75%	$28 → $28	Reiterates	Buy → Buy	Get Alert
04/02/2025	Buy Now	—	Guggenheim	Yatin Suneja72%	—	Reiterates	Buy → Buy	Get Alert
04/02/2025	Buy Now	94.31%	Needham	Joseph Stringer75%	$28 → $28	Reiterates	Buy → Buy	Get Alert
03/10/2025	Buy Now	-16.72%	Goldman Sachs	Paul Choi61%	$18 → $12	Maintains	Neutral	Get Alert
03/07/2025	Buy Now	94.31%	HC Wainwright & Co.	Matthew Caufield75%	$28 → $28	Reiterates	Buy → Buy	Get Alert
03/06/2025	Buy Now	94.31%	Needham	Joseph Stringer75%	$28 → $28	Reiterates	Buy → Buy	Get Alert
01/10/2025	Buy Now	94.31%	Needham	Joseph Stringer75%	$28 → $28	Reiterates	Buy → Buy	Get Alert
12/12/2024	Buy Now	94.31%	HC Wainwright & Co.	Matthew Caufield75%	$28 → $28	Reiterates	Buy → Buy	Get Alert
12/11/2024	Buy Now	94.31%	Needham	Joseph Stringer75%	$28 → $28	Reiterates	Buy → Buy	Get Alert
09/13/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
09/06/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
08/30/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
08/23/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
08/19/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
08/12/2024	Buy Now	94.31%	HC Wainwright & Co.	Matthew Caufield75%	$28 → $28	Reiterates	Buy → Buy	Get Alert
08/12/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
08/09/2024	Buy Now	-16.72%	Goldman Sachs	Paul Choi61%	$10 → $12	Maintains	Neutral	Get Alert
07/26/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
07/22/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
07/19/2024	Buy Now	94.31%	HC Wainwright & Co.	Matthew Caufield75%	$28 → $28	Reiterates	Buy → Buy	Get Alert
07/19/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
07/12/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
07/08/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
06/28/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
06/21/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
06/14/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
06/07/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
05/31/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
05/24/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
05/17/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
05/10/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
05/10/2024	Buy Now	94.31%	HC Wainwright & Co.	Matthew Caufield75%	$28 → $28	Reiterates	Buy → Buy	Get Alert
05/09/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
05/08/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
05/03/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
05/03/2024	Buy Now	66.55%	Stifel	Annabel Samimy70%	→ $24	Initiates	→ Buy	Get Alert
04/26/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
04/19/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
04/12/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
04/11/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
04/05/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
04/01/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
03/22/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
03/15/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Maintains	Buy	Get Alert
03/08/2024	Buy Now	94.31%	HC Wainwright & Co.	Matthew Caufield75%	$28 → $28	Reiterates	Buy → Buy	Get Alert
03/08/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
03/07/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
02/23/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
02/16/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
02/09/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$26 → $26	Reiterates	Buy → Buy	Get Alert
01/05/2024	Buy Now	80.43%	Needham	Joseph Stringer75%	$23 → $26	Maintains	Buy	Get Alert
11/10/2023	Buy Now	59.61%	Needham	Joseph Stringer75%	→ $23	Reiterates	Buy → Buy	Get Alert
11/03/2023	Buy Now	-30.6%	Goldman Sachs	Paul Choi61%	$9 → $10	Maintains	Neutral	Get Alert
09/27/2023	Buy Now	59.61%	Needham	Joseph Stringer75%	→ $23	Reiterates	Buy → Buy	Get Alert
08/11/2023	Buy Now	94.31%	HC Wainwright & Co.	Matthew Caufield75%	→ $28	Reiterates	Buy → Buy	Get Alert
08/11/2023	Buy Now	59.61%	Needham	Joseph Stringer75%	→ $23	Reiterates	Buy → Buy	Get Alert
08/09/2023	Buy Now	94.31%	HC Wainwright & Co.	Matthew Caufield75%	→ $28	Initiates	→ Buy	Get Alert
06/12/2023	Buy Now	59.61%	Needham	Joseph Stringer75%	→ $23	Reiterates	→ Buy	Get Alert
05/11/2023	Buy Now	—	Evercore ISI Group	Umer Raffat48%	—	Upgrade	In-Line → Outperform	Get Alert
04/19/2023	Buy Now	59.61%	Needham	Joseph Stringer75%	→ $23	Reiterates	→ Buy	Get Alert
04/05/2023	Buy Now	59.61%	Needham	Joseph Stringer75%	→ $23	Reiterates	→ Buy	Get Alert
03/13/2023	Buy Now	45.73%	Craig-Hallum	Chase Knickerbocker74%	→ $21	Initiates	→ Buy	Get Alert
03/01/2023	Buy Now	108.19%	BMO Capital	Gary Nachman62%	$35 → $30	Maintains	Outperform	Get Alert
02/10/2023	Buy Now	59.61%	Needham	Joseph Stringer75%	$25 → $23	Maintains	Buy	Get Alert
01/04/2023	Buy Now	142.89%	BMO Capital	Gary Nachman62%	$38 → $35	Maintains	Outperform	Get Alert
01/04/2023	Buy Now	73.49%	Needham	Joseph Stringer75%	$38 → $25	Maintains	Buy	Get Alert

PREGUNTAS FRECUENTES

¿Cuál es el precio objetivo de las acciones de Phathom Pharmaceuticals (PHAT)?

El último precio objetivo de Phathom Pharmaceuticals (NASDAQ:PHAT) fue comunicado por HC Wainwright & Co. el octubre 31, 2025. La firma de analistas fijó un precio objetivo para $26.00 que espera PHAT a rise dentro de 12 meses (un posible 80.43% upside). 19 firmas de analistas han reportado calificaciones en el último año.

¿Cuál es la calificación más reciente de los analistas sobre Phathom Pharmaceuticals (PHAT)?

La última calificación de analistas para Phathom Pharmaceuticals (NASDAQ:PHAT) fue proporcionada por HC Wainwright & Co., y Phathom Pharmaceuticals mantuvo su buy calificación.

¿Cuándo se produjo la última revisión al alza de Phathom Pharmaceuticals (PHAT)?

La última revisión al alza de Phathom Pharmaceuticals Inc se produjo en mayo 11, 2023, cuando Evercore ISI Group elevó su precio objetivo a N/A. Evercore ISI Group anteriormente tenía an in-line para Phathom Pharmaceuticals Inc.

¿Cuándo fue la última revisión a la baja de Phathom Pharmaceuticals (PHAT)?

No hay una última revisión a la baja para Phathom Pharmaceuticals.

¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Phathom Pharmaceuticals (PHAT)?

Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Phathom Pharmaceuticals, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Phathom Pharmaceuticals se registró el octubre 31, 2025, por lo que la próxima calificación estará disponible en torno al octubre 31, 2026.

¿Es correcta la calificación de los analistas sobre Phathom Pharmaceuticals (PHAT)?

Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Phathom Pharmaceuticals (PHAT) fue un mantuvo con un precio objetivo de $20.00 a $26.00. El precio actual al que cotiza Phathom Pharmaceuticals (PHAT) es de $14.41, que es out of del rango previsto por el analista.

Explora calificaciones de analistas y precios objetivo sobre todos los valores.